热门资讯> 正文
Artelo Biosciences启动公开募股;股价下跌10%
2025-09-04 04:50
- Artelo Biosciences (NASDAQ:ARTL) has commenced an underwritten public offering of common stock and/or pre-funded warrants.
- All securities in the offering will be sold by the company itself.
- The size, pricing, and terms of the offering are yet to be determined.
- Proceeds are expected to support the company’s clinical-stage programs targeting cancer, pain, and neurological conditions.
- ARTL shares down 9.9% post-market on Wednesday.
- Source: Press release
More on AtkinsRéalis Group Inc.
- AtkinsRéalis Group Inc. 2025 Q2 - Results - Earnings Call Presentation
- AtkinsRéalis Group Inc. Q2 2025 Earnings Call Transcript
- AtkinsRéalis to repurchase 7M shares from La Caisse
- Historical earnings data for AtkinsRéalis Group Inc.
- Dividend scorecard for AtkinsRéalis Group Inc.
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
